{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:16:40Z","timestamp":1773281800989,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2004,3,19]],"date-time":"2004-03-19T00:00:00Z","timestamp":1079654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1038\/sj.eye.6701375","type":"journal-article","created":{"date-parts":[[2004,3,23]],"date-time":"2004-03-23T12:33:28Z","timestamp":1080045208000},"page":"990-995","source":"Crossref","is-referenced-by-count":25,"title":["Efficacy and safety of the latanoprost\/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy"],"prefix":"10.1038","volume":"18","author":[{"given":"W C","family":"Stewart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J A","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D G","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E D","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J N","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,3,19]]},"reference":[{"key":"BF6701375_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1034\/j.1600-0420.2003.00065.x","volume":"81","author":"WC Stewart","year":"2003","unstructured":"Stewart WC, Stewart JA, Day D, Sharpe ED . Efficacy and safety of latanoprost\/timolol maleate fixed combination versus timolol maleate and brimonidine given twice daily. Acta Ophthalmol Scand 2003; 81: 242\u2013246.","journal-title":"Acta Ophthalmol Scand"},{"key":"BF6701375_CR2","first-page":"117","volume-title":"Essentials of Statistics","author":"SA Book","year":"1978","unstructured":"Book SA Essentials of Statistics. McGraw Hill Book Company: New York, 1978, pp 117\u2013122, 205\u2013215."},{"key":"BF6701375_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1089\/jop.1998.14.129","volume":"14","author":"TK Mundorf","year":"1998","unstructured":"Mundorf TK, Cate EA, Sine CS, Otero DW, Stewart JA, Stewart WC . The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily. J Ocular Pharm Therap 1998; 14: 129\u2013135.","journal-title":"J Ocular Pharm Therap"},{"key":"BF6701375_CR4","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1755-3768.1987.tb07052.x","volume":"65","author":"GR Duff","year":"1987","unstructured":"Duff GR . A double-masked crossover study comparing the effects of carteolol 1% and 2% on intraocular pressure. Acta Ophthalmol 1987; 65: 618\u2013621.","journal-title":"Acta Ophthalmol"},{"key":"BF6701375_CR5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0002-9394(00)00381-0","volume":"129","author":"WC Stewart","year":"2000","unstructured":"Stewart WC, Sharpe ED, Harbin Jr TS, Pastor SA, Day DG, Holmes KT et al. Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce the intraocular pressure. Am J Ophthalmol 2000; 129: 723\u2013727.","journal-title":"Am J Ophthalmol"},{"key":"BF6701375_CR6","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0002-9394(99)00237-8","volume":"128","author":"WC Stewart","year":"1999","unstructured":"Stewart WC, Day DG, Sharpe ED, Dubiner HB, Holmes KT, Stewart JA . Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost. Am J Ophthalmol 1999; 128: 692\u2013696.","journal-title":"Am J Ophthalmol"},{"key":"BF6701375_CR7","first-page":"63","volume-title":"Nonparametric Statistics for the Behavioral Science. Series in Psychology","author":"S Siegel","year":"1956","unstructured":"Siegel S Nonparametric Statistics for the Behavioral Science. Series in Psychology. McGraw Hill Book Company,. New York, 1956, pp 63\u201367."},{"issue":"suppl","key":"BF6701375_CR8","first-page":"S754","volume":"41","author":"N Pfeiffer","year":"2000","unstructured":"Pfeiffer N, and the German Latanoprost Fixed Combination Study Group. A comparison of the fixed combination of latanoprost and timolol with IST individual components in patients with glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci 2000; 41 (suppl): S754.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF6701375_CR9","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/archopht.120.7.915","volume":"120","author":"EJ Higginbotham","year":"2002","unstructured":"Higginbotham EJ, Feldman R, Stiles M, Dubiner H, Fixed Combination Investigative Group. Latanoprost and timolol combination therapy versus monotherapy. Arch Ophthalmol 2002; 120: 915\u2013922.","journal-title":"Arch Ophthalmol"},{"key":"BF6701375_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0002-9394(00)00902-8","volume":"131","author":"WC Stewart","year":"2001","unstructured":"Stewart WC, Day DG, Stewart JA, Schuhr J, Latham KE . The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2001; 131: 631\u2013635.","journal-title":"Am J Ophthalmol"},{"key":"BF6701375_CR11","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S0002-9394(00)00930-2","volume":"131","author":"WC Stewart","year":"2001","unstructured":"Stewart WC, Holmes KT, Johnson MA . Washout periods for brimonidine 0.2% and latanoprost 0.005%. Am J Ophthalmol 2001; 131: 798\u2013799.","journal-title":"Am J Ophthalmol"},{"key":"BF6701375_CR12","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","volume":"102","author":"A Alm","year":"1995","unstructured":"Alm A, Stjernschantz J and the Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning: a comparison with timolol. Ophthalmology 1995; 102: 1743\u20131752.","journal-title":"Ophthalmology"},{"key":"BF6701375_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","volume":"103","author":"CB Camras","year":"1996","unstructured":"Camras CB and the United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month, masked, multicenter trial in the United States. Ophthalmology 1996; 103: 138\u2013147.","journal-title":"Ophthalmology"},{"key":"BF6701375_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0161-6420(96)30750-1","volume":"103","author":"P Watson","year":"1996","unstructured":"Watson P, Stjernschantz J, and the Latanoprost Study Group. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology 1996; 103: 126\u2013137.","journal-title":"Ophthalmology"},{"key":"BF6701375_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0002-9394(99)00073-2","volume":"128","author":"AGP Konstas","year":"1999","unstructured":"Konstas AGP, Maltezos AC, Gandi S, Hudgins AC, Stewart WC . Comparison of the 24 hour intraocular pressure reduction with two dosing regimes of latanoprost and timolol in patients with open-angle glaucoma. Am J Ophthalmol 1999; 128: 15\u201320.","journal-title":"Am J Ophthalmol"},{"key":"BF6701375_CR16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0002-9394(02)01460-5","volume":"133","author":"AGP Konstas","year":"2002","unstructured":"Konstas AGP, Nakos E, Tersis I, Lallos NA, Leech JN, Stewart WC . A comparison of once daily morning versus evening dosing of concomitant latanoprost\/timolol. Am J Ophthalmol 2002; 133: 753\u2013757.","journal-title":"Am J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6701375.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701375","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701375.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:16:16Z","timestamp":1684412176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6701375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,19]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["BF6701375"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6701375","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,19]]}}}